🌿 Independent & nonprofit · NY-first · 21+

Cannabis facts, tagged by the evidence.

A nonprofit guide that tells you what the retail market won't — what's settled, what's marketing, and what to avoid. No ads. No menus. No spin.

Start learningSee what the review found
4 tiers every claim is rated
$0 from dispensaries or ads
NY-first built on OCM public data
The trust feature

Every line wears its evidence

Tap a tier to filter the claims below. Settled = strong human evidence · Emerging = early/preclinical · Contested = mixed · Marketing = a sales claim the science doesn't back.

Showing all claims.

Cannabis 101, honestly

Learn

Radical transparency

What the review found

We pressure-tested this whole idea with four AI models and three independent red-teams. Here's the honest result — because hiding it would betray the point.

✓ Agreed on

  • Education-first, no in-app sales = lowest risk.
  • Nonprofit neutrality is the real wedge.
  • Indica/sativa → chemovar is correct.
  • Evidence-honesty is the differentiator.

⚠ Red flags

  • No proven audience for neutral education decoupled from buying.
  • Grant funding is fragile (foundation cannabis no-touch policies).
  • Legal: IRS 501(c)(3) illegality doctrine; FDA drug-claims jurisdiction; NY Part 129 "90%-21+" vs a no-accounts site.
  • Open social = de-platforming risk.

→ The pivots

  • Reposition as harm-reduction / public-health.
  • Ship the data as a B2B2C "Intel Inside" API.
  • Educator directory = independent clinicians only.
Concept · Phase 2 · flagged by the review

The product, mocked up

What the full experience could feel like — sign-up, profiles, and a moderated community. The community layer is a real launch risk, so it's a later, clinician-moderated bet, not day one.

Sign up

Learn from evidence, not a menu.

First — are you 21+? (NY law)

Yes, 21+
Under 21
you@email.com
pick a handle
Create free account

Education only. We never sell cannabis, take ad money, or sell your data.

Profile⚙
@brooklyn_newleaf
joined this week · NY
Myth-busterDosing-awareLabel-reader

Evidence-literacy badges — earned by finishing modules, not by buying.

Saved
Indica/sativa myth · Routes & onset · Green-out
Streak
5 days learning · 0 ads seen
Community mock＋
@first_timer_q
“Edible did nothing for an hour — take more?”
✓ Clinician No — edibles peak at 1–3h. Re-dosing early is the #1 cause of greening out. Wait.
@terp_curious
“Is myrcene really what makes me sleepy?”
✓ Clinician Popular claim, thin evidence — we tag it Marketing.

Sample data. No buying, prices, or dispensary talk — ever. Clinician-moderated.

No scraping, no spin

Built on real, public data

We use data we're actually allowed to use, and cite it. The proprietary stuff (private menus and prices) we don't touch.

🟢 NY OCM open data

data.ny.gov publishes the licensed-operator dataset. Powers "is this shop actually licensed?"

✓ Licensed · NY OCM
🟢 OCM recalls

Official recall pages → real safety alerts.

⚠ Recall: Batch #NY-2241 failed a pesticide screen. Stop use.
🟢 Peer-reviewed science

Open-access PubMed/PMC reviews — every claim cited and re-checked.

⛔ Leafly / Weedmaps menus

Proprietary and ToS-protected. We don't scrape prices or inventory.

Support Counter